1. Buffet, Alexandre, Burnichon, Nelly, Favier, Judith, Gimenez-Roqueplo, Anne-Paule. 2020. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. In Best practice & research. Clinical endocrinology & metabolism, 34, 101416. doi:10.1016/j.beem.2020.101416. https://pubmed.ncbi.nlm.nih.gov/32295730/
2. Hu, Mu, Yang, JieLai, Xu, Yang, Liu, Jiao. 2022. MDH1 and MDH2 Promote Cell Viability of Primary AT2 Cells by Increasing Glucose Uptake. In Computational and mathematical methods in medicine, 2022, 2023500. doi:10.1155/2022/2023500. https://pubmed.ncbi.nlm.nih.gov/36158123/
3. Chen, Yong-Hong, Liu, Shu-Jing, Gao, Mei-Mei, Yi, Yong-Hong, Long, Yue-Sheng. 2017. MDH2 is an RNA binding protein involved in downregulation of sodium channel Scn1a expression under seizure condition. In Biochimica et biophysica acta. Molecular basis of disease, 1863, 1492-1499. doi:10.1016/j.bbadis.2017.04.018. https://pubmed.ncbi.nlm.nih.gov/28433711/